🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

BREAKING: Your brain’s connective tissue isn’t just glue: It’s a switchboard for neuromodulation. We used to think that astrocytes (the beautiful star-shaped glial cells) were the brain’s 'support staff.' But thanks to exciting new work from Guttenplan and colleagues this week in

This is MASSIVE!!

🚨🆕 Expert consensus on #CardiogenicShock in women. Sex-based disparities in #CS care contribute to worse outcomes for women. This global statement from SCAI, EAPCI, and ACVC outlines gaps, guidance, and the path forward. Read the statement➡️ doi.org/10.1016/j.jsca… European Society of Cardiology

CATHEDRAL-HF: Withdrawal of other #HeartFailure treatment while maintaining carvedilol as a single therapy did not worsen left ventricular function compared to usual treatment at 52 weeks in patients w/ HFimpEF. Read more: bit.ly/44IEuId #JACCHF JACC Journals

Men who participate in high-volume endurance exercise have greater atherosclerotic risk vs. nonathletes and women who exercise at a similar intensity Leandro Slipczuk Albert Einstein College of Medicine - Official Montefiore Health System Healio #SportsCardiology healio.com/news/cardiolog…

I’m always eager for updates on antiplatelet agents, so I thought it was worth sharing that CeleBrate, the pivotal Phase 3 trial of the subcutaneous GPIIb/IIIa inhibitor zalunfiban, has been completed. Results are expected in Q3 2025—possibly at AHA? The drug is being developed

#Europace #Epeeps ⏲️Impact of diagnosis-to-ablation time on #AF recurrences and clinical outcomes: A meta-analysis 📑doi.org/10.1093/europa… @GiulioConte Francesco Santoro, MD, PhD Marco Vitolo Ⓜ️ Dominik Linz Davide Mei Xiaodong Zhang (Andy), MD, PhD, FHRS, FACC Luigi Di Biase European Society of Cardiology Journals European Society of Cardiology

A pooled analysis from three of our Phase 3 studies evaluated obicetrapib’s effect on Lp(a) in people at increased risk for cardiovascular disease, particularly in those with baseline Lp(a) from 50-150 nmo/L. See the data shared at #NLASessions: bit.ly/3SXDyZd

Pericoronary adipose tissue (PCAT) attenuation on CCTA is a novel marker linked to increased cardiac mortality and major events. This study shows that PCAT attenuation independently predicts adverse outcomes after PCI and improves risk stratification when added to standard CCTA

Reevaluating Beta-Blocker Recommendations Post-Myocardial Infarction: Perspective on the 2025 Guideline Update: JACC Journals 🥸Commentary on the guidelines - early beta blocker use post MI - 😱Michael Nanna wrote extensively on this in older pts. 🥸Take a look 👇👇👇

Our new JAMA Cardiology study finds that many US adults don't know that they have hypertension, diabetes, or high cholesterol Nearly 1 in 3 young adults w/ hypertension, 2 in 5 with diabetes, and 1 in 4 with high cholesterol are unaware of their condition. bit.ly/45an6MC

Coronary artery build-up linked to high-volume exercise: What cardiologists need to know beckershospitalreview.com/cardiology/cor… Ahmed Abdelaziz, MD Montefiore Heart Montefiore Health System Carl Lavie

COMPARE STEMI ONE is the first RCT to assess 1-month DAPT followed by prasugrel monotherapy in STEMI patients. Also evaluated OCT-guided vs. angiography-guided staged PCI for non-culprit lesions. Protocol published 👇eurointervention.pcronline.com/article/prasug… #DAPT #STEMI #OCT #PCI #rctst

A great addition to the colchicine era.

Alhamdulillah, One of the most important papers I’ve been waiting for has finally been published, and I’m proud to be the second author. I’m truly happy and deeply grateful to Ahmed Abdelaziz, MD for everything he’s done for me and taught me, and many for dr Leandro Slipczuk

🎉Congrats to Dr. Leandro Slipczuk Leandro Slipczuk of Montefiore Health System on his groundbreaking research! 🔬 Discover how exercise volume affects sex-specific #atherosclerotic risk in our exclusive Physician's Weekly Q&A with Dr. Slipczuk here: bit.ly/3HTiVLq #MedTwitter

I’m excited to finally share our recent publication in the EJPC! It has been an incredible opportunity to work under the outstanding supervision Ahmed Abdelaziz, MD. I was also fortunate to collaborate with my dear brothers Ahmed Elshahat Ahmed Sobhy,MD

I am pleased to announce that the new Impact Factor of EuroIntervention is the highest in its 20-year history: 9.5. Ranked 16th out of 230 journals in the cardiovascular category (+5 positions versus the previous year). Thank you all — it’s an exciting rollercoaster.

Very happy to announce the new impact factor of Progress in Cardiovascular Diseases at 7.6 placing the journal #22 out of 230 CV journals! Dr. Deepak L. Bhatt MIЯVΛƬ #IC Eugenio Cingolani, MD Juan Pablo Costabel MD 🇦🇷 Damini Dey Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 Sanjay Kaul Jari Laukkanen Ahmad Masri Michael D. Shapiro Piotr Slomka PhD

I regret to inform you that my little son, Tamim, passed away yesterday. It has been a very long journey, and yet this chapter was sadly closed forever. Just recovering.